Literature DB >> 21928152

α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.

Isabel Ubeda-Bañon1, Daniel Saiz-Sanchez, Carlos de la Rosa-Prieto, Alino Martinez-Marcos.   

Abstract

Olfactory deficits are an early feature of Parkinson's disease (PD). Neuropathologically, α-synucleinopathy (Lewy bodies and neurites) is observed earlier (stage 1) in the olfactory system than in the substantia nigra (stage 3), and this could underlies the early olfactory symptoms. In the present report, we analyzed the distribution of α-synuclein deposits in tertiary olfactory structures (anterior olfactory nucleus, olfactory tubercle, piriform cortex, posterolateral cortical amygdala and lateral entorhinal cortex) of homozygous transgenic mice (aged 2-8 months) overexpressing the human A53T variant of α-synuclein. To address the hypothesis of progressive α-synucleinopathy within the olfactory system, the distribution of α-synuclein was analyzed in conjunction with tracer injections into the main olfactory bulb. The time-course of α-synuclein expression revealed a significant increase in the piriform cortex at the age of 8 months compared to other brain structures. Tracing experiments revealed that olfactory projections are reduced in homozygous as compared to wild type animals. Double-labeling experiments show labeled axonal collaterals of mitral cells entering layer II of the piriform cortex in close proximity to α-synuclein-positive cells. To our knowledge, this is the first study addressing the progression of α-synuclein expression in a vulnerable neuronal pathway in PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928152     DOI: 10.1007/s00429-011-0347-4

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  6 in total

Review 1.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

2.  Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Teresa Alberts; Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Oliver Schmitt; Jens Kurth; Jan Stenzel; Tobias Lindner; Bernd J Krause; Andreas Wree; Martin Witt
Journal:  Toxins (Basel)       Date:  2022-01-25       Impact factor: 4.546

3.  The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease.

Authors:  Jackalina M Van Kampen; David C Baranowski; Harold A Robertson; Christopher A Shaw; Denis G Kay
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

4.  Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.

Authors:  Stefan Kurtenbach; Sonja Wewering; Hanns Hatt; Eva M Neuhaus; Hermann Lübbert
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.

Authors:  Alicia Flores-Cuadrado; Daniel Saiz-Sanchez; Alicia Mohedano-Moriano; Alino Martinez-Marcos; Isabel Ubeda-Bañon
Journal:  Acta Neuropathol Commun       Date:  2019-04-15       Impact factor: 7.801

Review 6.  Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.

Authors:  Yeojin Bang; Juhee Lim; Hyun Jin Choi
Journal:  Arch Pharm Res       Date:  2021-06-19       Impact factor: 4.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.